Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

What’s at stake in the face the enforcement deadlines and how exception management lays the groundwork for future-ready ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

This will support the development of mRNA-based vaccines and improve access in low- and middle-income countries.

Platinum Press Inc. (PPI) has commenced runs utilizing a digital printing system whose inks are free of volatile organic ...

Lonza has appointed Andreas Bohrer to the newly created role of Chief Legal & Corporate Affairs Officer. Effective 1 July ...

AbbVie and ADARx Pharmaceuticals have signed a collaboration and license option agreement to develop small interfering RNA ...

The company also appointed Pete Buzy, former President and CEO of Catalent Cell & Gene Therapy, to its Board of Directors.

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

The partnership combines AKBA’s industry knowledge and product expertise with PeptiSystems’ next-generation synthesizers.

Forge Biologics has entered an AAV development and manufacturing agreement to help advance Fractyl Health’s Rejuva platform.